Pacer Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $348M | Buy |
4,845,221
+4,712,882
| +3,561% | +$363M | 0.98% | 20 |
|
|
2025
Q4 | $10.5M | Sell |
132,339
-26,456
| -17% | -$2.09M | 0.03% | 485 |
|
|
2025
Q3 | $12M | Buy |
158,795
+54,871
| +53% | +$3.76M | 0.03% | 439 |
|
|
2025
Q2 | $7.17M | Buy |
103,924
+39,616
| +62% | +$2.6M | 0.02% | 585 |
|
|
2025
Q1 | $4.36M | Sell |
64,308
-130,131
| -67% | -$7.79M | 0.01% | 708 |
|
|
2024
Q4 | $8.73M | Sell |
194,439
-438,606
| -69% | -$24.6M | 0.02% | 489 |
|
|
2024
Q3 | $39.8M | Buy |
633,045
+15,889
| +3% | +$927K | 0.08% | 240 |
|
|
2024
Q2 | $36.4M | Sell |
617,156
-5,504,982
| -90% | -$344M | 0.08% | 240 |
|
|
2024
Q1 | $488M | Buy |
6,122,138
+608,908
| +11% | +$46.5M | 1.12% | 10 |
|
|
2023
Q4 | $435M | Buy |
5,513,230
+616,785
| +13% | +$43.9M | 1.23% | 3 |
|
|
2023
Q3 | $342M | Buy |
4,896,445
+1,160,728
| +31% | +$82.2M | 1.31% | 7 |
|
|
2023
Q2 | $258M | Buy |
3,735,717
+351,945
| +10% | +$25M | 1.04% | 24 |
|
|
2023
Q1 | $251M | Buy |
3,383,772
+1,223,901
| +57% | +$103M | 1.07% | 26 |
|
|
2022
Q4 | $201M | Buy |
2,159,871
+653,318
| +43% | +$63M | 1.03% | 22 |
|
|
2022
Q3 | $144M | Buy |
1,506,553
+16,627
| +1% | +$1.65M | 1% | 16 |
|
|
2022
Q2 | $138M | Buy |
1,489,926
+645,114
| +76% | +$63M | 1.03% | 13 |
|
|
2022
Q1 | $85.5M | Buy |
844,812
+505,306
| +149% | +$53.1M | 0.7% | 23 |
|
|
2021
Q4 | $35M | Buy |
339,506
+260,518
| +330% | +$24.1M | 0.36% | 36 |
|
|
2021
Q3 | $6.7M | Sell |
78,988
-166,785
| -68% | -$14M | 0.08% | 273 |
|
|
2021
Q2 | $20.5M | Buy |
245,773
+81,261
| +49% | +$6.65M | 0.29% | 44 |
|
|
2021
Q1 | $12.4M | Buy |
164,512
+14,584
| +10% | +$1.06M | 0.22% | 63 |
|
|
2020
Q4 | $10.2M | Sell |
149,928
-26,260
| -15% | -$1.71M | 0.19% | 77 |
|
|
2020
Q3 | $10.3M | Sell |
176,188
-4,825
| -3% | -$300K | 0.22% | 82 |
|
|
2020
Q2 | $11.8M | Buy |
181,013
+180,135
| +20,517% | +$11.3M | 0.24% | 74 |
|
|
2020
Q1 | $56K | Hold |
878
| – | – | ﹤0.01% | 539 |
|
|
2019
Q4 | $65K | Sell |
878
-144,147
| -99% | -$10.1M | ﹤0.01% | 1190 |
|
|
2019
Q3 | $9.15M | Buy |
145,025
+18,765
| +15% | +$1.11M | 0.21% | 81 |
|
|
2019
Q2 | $6.88M | Buy |
126,260
+10,771
| +9% | +$580K | 0.17% | 98 |
|
|
2019
Q1 | $6.23M | Buy |
+115,489
| New | +$7.13M | 0.17% | 97 |
|
|
2018
Q4 | – | Sell |
-138,044
| Closed | -$10.9M | – | 664 |
|
|
2018
Q3 | $10.9M | Buy |
138,044
+50,695
| +58% | +$3.62M | 0.41% | 37 |
|
|
2018
Q2 | $5.62M | Buy |
87,349
+41,050
| +89% | +$2.71M | 0.25% | 56 |
|
|
2018
Q1 | $2.88M | Buy |
46,299
+6,096
| +15% | +$437K | 0.16% | 113 |
|
|
2017
Q4 | $2.92M | Buy |
40,203
+5,106
| +15% | +$371K | 0.2% | 74 |
|
|
2017
Q3 | $2.85M | Buy |
35,097
+2,543
| +8% | +$201K | 0.25% | 58 |
|
|
2017
Q2 | $2.62M | Buy |
32,554
+1,808
| +6% | +$143K | 0.26% | 55 |
|
|
2017
Q1 | $2.41M | Buy |
30,746
+2,663
| +9% | +$213K | 0.3% | 48 |
|
|
2016
Q4 | $2.22M | Buy |
28,083
+2,412
| +9% | +$195K | 0.32% | 44 |
|
|
2016
Q3 | $2.29M | Sell |
25,671
-130
| -0.5% | -$12.3K | 0.35% | 43 |
|
|
2016
Q2 | $2.47M | Buy |
25,801
+1,380
| +6% | +$138K | 0.39% | 41 |
|
|
2016
Q1 | $2.53M | Sell |
24,421
-375
| -2% | -$36.5K | 0.57% | 37 |
|
|
2015
Q4 | $2.42M | Buy |
24,796
+20,040
| +421% | +$1.96M | 0.57% | 37 |
|
|
2015
Q3 | $459K | Hold |
4,756
| – | – | 1.12% | 28 |
|
|
2015
Q2 | $499K | Hold |
4,756
| – | – | 1.04% | 25 |
|
|
2015
Q1 | $491K | Buy |
+4,756
| New | +$481K | 1.02% | 25 |
|
|
2013
Q4 | $3.15M | Buy |
+32,750
| New | +$2.1M | 0.76% | 19 |
|
Other funds holding CVS
VCM
VPM
Pacer Advisors's CVS Position: Q1 2026 in Review
Pacer Advisors increased its CVS Health (CVS) stake by 3,561% in Q1 2026, buying an estimated $363M and bringing the position to 4,845,221 shares worth $348M. The position accounts for 0.98% of the portfolio, ranked #20.
Pacer Advisors first reported a position in CVS in Q4 2013 and has held it in 45 quarters since. The position peaked at $488M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Pacer Advisors held 4,845,221 shares of CVS Health worth $348M as of Q1 2026.
- Pacer Advisors bought 4,712,882 CVS Health shares in Q1 2026, an estimated $363M.
- CVS Health made up 0.98% of Pacer Advisors's portfolio in Q1 2026, its #20 holding.
- Pacer Advisors first reported a position in CVS Health in Q4 2013 and has held it in 45 quarters since.
- Pacer Advisors's CVS Health position peaked at $488M in Q1 2024.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.